FIELD: organic chemistry, biochemistry, enzymes. SUBSTANCE: invention relates to compounds of the formulas (I) 
and (II) 
with values of radicals R1-R18 described in description that show ability to inhibit activity of prenyltransferases. Compounds are effective inhibitors of tumor cells proliferation also. Invention describes also dimeric compounds comprising residues of compounds of the formulas (I) and (II) and a method of treatment of tumors or restenosis in patient that involves administration of these compounds to patient. EFFECT: valuable medicinal properties of compounds. 17 cl
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF PRENYLTRANSFERASES | 1997 |
|
RU2201925C2 |
| PEPTIDES WITH AFFINITY FOR PARATHYROID HORMONE AND ACTIVITY- STIMULATING ADENYLCYCLASES | 1996 |
|
RU2157699C2 |
| ANALOGS OF PARATHYROID GLAND HORMONE | 1997 |
|
RU2198182C2 |
| BICYCLIC ARYL MONOBACTAM COMPOUNDS AND METHODS OF USING SAID COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | 2017 |
|
RU2733402C2 |
| BENZAZEPINE DICARBOXAMIDE COMPOUND | 2016 |
|
RU2712248C2 |
| BIARILE MONOBACTAM COMPOUNDS AND METHODS OF THEIR APPLICATION FOR TREATMENT OF BACTERIAL INFECTIONS | 2016 |
|
RU2746129C2 |
| SULFUR-CONTAINING COMPOUNDS, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL PREPARATIONS BASED ON THEREOF | 2000 |
|
RU2244708C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
| APPLICATION OF REMYELINATING MEDICATION FOR STIMULATION OF NERVE CELLS IN CASE OF DEMYELINATING DISEASE | 2004 |
|
RU2412721C2 |
| GLUTAMIC ACID DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF GROWTH AND PROLIFERATION OF CELLS | 1994 |
|
RU2136686C1 |
